Economy

Trump backs down from 250% EU pharma tariff in deal

Trump steps away from 250% EU pharma tariff in latest agreement

The rising trade disputes between Washington and Brussels reached a pivotal point when former U.S. President Donald Trump decided to abandon proposals to introduce an unusually steep tariff—allegedly 250 percent—on pharmaceutical goods imported from the European Union. This move, included in a broader trade agreement, represents a crucial development in the prolonged discussions between the two significant economic forces and provides a temporary relief for businesses on both sides of the Atlantic.The conflict originated during a time of escalating trade tensions when Washington aimed to address perceived ongoing disparities and unjust practices across industries like agriculture, technology, and healthcare. Pharmaceuticals…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump abandons 250% EU pharma tariff following deal

The rising trade disputes between Washington and Brussels reached a pivotal point when former U.S. President Donald Trump decided to abandon proposals to introduce an unusually steep tariff—allegedly 250 percent—on pharmaceutical goods imported from the European Union. This move, included in a broader trade agreement, represents a crucial development in the prolonged discussions between the two significant economic forces and provides a temporary relief for businesses on both sides of the Atlantic.The conflict originated during a time of escalating trade tensions when Washington aimed to address perceived ongoing disparities and unjust practices across industries like agriculture, technology, and healthcare. Pharmaceuticals…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump reverses stance on 250% EU pharma tariff after deal

The escalating trade tensions between Washington and Brussels took a significant turn as former U.S. President Donald Trump agreed to withdraw plans for imposing an extraordinarily high tariff—reportedly 250 percent—on pharmaceutical imports from the European Union. This decision, which came as part of a broader trade arrangement, marks a critical moment in the long-standing negotiations between the two economic powerhouses and offers a temporary reprieve for industries on both sides of the Atlantic.The conflict originated during a time of escalating trade tensions when Washington aimed to address perceived ongoing disparities and unjust practices across industries like agriculture, technology, and healthcare.…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump retreats from 250% EU pharma tariff amid agreement

The likelihood of a trade conflict between the United States and the European Union has been avoided after former U.S. President Donald Trump decided not to implement a significant duty on pharmaceutical products from Europe. At first, the Trump administration had indicated plans to impose a 250% duty on medications from Europe, which concerned both industry executives and health organizations globally. Nevertheless, after several weeks of intense discussions, both parties have declared an agreement designed to preserve stability in the global pharmaceutical industry.The suggested tariff was introduced as a component of a larger plan aimed at safeguarding manufacturing in the…
Read More
US in talks over 10% Intel stake, White House confirms

US in negotiations for 10% Intel stake, White House confirms

The government of the United States is said to be evaluating a major action that could transform the future of the semiconductor sector. Talks have emerged regarding the potential acquisition of as much as a 10 percent interest in Intel, a leading chip manufacturer globally. This notion illustrates the increasing worry about technological autonomy, national defense, and international competition in a domain that serves as the foundation for nearly every contemporary industry.The proposal aligns with broader efforts to strengthen domestic chip production. Semiconductors are essential for computers, smartphones, vehicles, military systems, and countless connected devices that define modern life. The…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump softens stance on 250% EU pharma tariff in deal

The likelihood of a trade conflict between the United States and the European Union has been avoided after former U.S. President Donald Trump decided not to implement a significant duty on pharmaceutical products from Europe. At first, the Trump administration had indicated plans to impose a 250% duty on medications from Europe, which concerned both industry executives and health organizations globally. Nevertheless, after several weeks of intense discussions, both parties have declared an agreement designed to preserve stability in the global pharmaceutical industry.The suggested tariff was introduced as a component of a larger plan aimed at safeguarding manufacturing in the…
Read More
US in talks over 10% Intel stake, White House confirms

US considers 10% Intel stake, confirmed by White House

The government of the United States is said to be evaluating a major action that could transform the future of the semiconductor sector. Talks have emerged regarding the potential acquisition of as much as a 10 percent interest in Intel, a leading chip manufacturer globally. This notion illustrates the increasing worry about technological autonomy, national defense, and international competition in a domain that serves as the foundation for nearly every contemporary industry.The proposal aligns with broader efforts to strengthen domestic chip production. Semiconductors are essential for computers, smartphones, vehicles, military systems, and countless connected devices that define modern life. The…
Read More
US in talks over 10% Intel stake, White House confirms

US negotiating 10% Intel stake, White House confirms

The government of the United States is said to be evaluating a major action that could transform the future of the semiconductor sector. Talks have emerged regarding the potential acquisition of as much as a 10 percent interest in Intel, a leading chip manufacturer globally. This notion illustrates the increasing worry about technological autonomy, national defense, and international competition in a domain that serves as the foundation for nearly every contemporary industry.The proposal aligns with broader efforts to strengthen domestic chip production. Semiconductors are essential for computers, smartphones, vehicles, military systems, and countless connected devices that define modern life. The…
Read More
Newsmax settles Dominion election defamation case for m

Newsmax and Dominion settle election defamation lawsuit for $67m

Newsmax has settled its legal disagreement with Dominion Voting Systems by consenting to a $67 million payment, concluding a significant defamation case associated with the 2020 U.S. presidential election. This settlement stops the case from advancing to trial and highlights the financial and reputational impacts that media organizations may encounter when covering claims that are unsupported by verified evidence.Dominion Voting Systems, una empresa que suministró tecnología electoral y máquinas de tabulación en todo Estados Unidos, se convirtió en un objetivo central de campañas de desinformación tras las elecciones de 2020. Acusaciones infundadas sobre la manipulación de resultados por parte de…
Read More
Newsmax settles Dominion election defamation case for m

Newsmax agrees to $67m settlement in Dominion election defamation lawsuit

Newsmax has settled its legal disagreement with Dominion Voting Systems by consenting to a $67 million payment, concluding a significant defamation case associated with the 2020 U.S. presidential election. This settlement stops the case from advancing to trial and highlights the financial and reputational impacts that media organizations may encounter when covering claims that are unsupported by verified evidence.Dominion Voting Systems, a company that provided election technology and tabulation machines across the United States, became a central target of misinformation campaigns after the 2020 election. Unfounded allegations that Dominion’s systems had manipulated results spread rapidly, amplified by public figures and…
Read More